Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

被引:130
|
作者
Buchheit, Kathleen M. [1 ,3 ]
Cahill, Katherine N. [1 ,3 ]
Katz, Howard R. [1 ,3 ]
Murphy, Katherine C. [3 ]
Feng, Chunli [3 ]
Lee-Sarwar, Kathleen [1 ]
Lai, Juying [3 ]
Bhattacharyya, Neil [2 ,4 ]
Israel, Elliot [1 ,5 ]
Boyce, Joshua A. [1 ,3 ]
Laidlaw, Tanya M. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Otolaryngol, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Pulm Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Aspirin-exacerbated respiratory disease; Samter triad; nasal polyps; thymic stromal lymphopoietin; prostaglandin D-2; cysteinyl leukotrienes; innate immunity; mast cells; eosinophils; INNATE LYMPHOID-CELLS; HUMAN EPITHELIAL-CELLS; MAST-CELL; EOSINOPHILIC INFLAMMATION; CYSTEINYL LEUKOTRIENES; CHRONIC RHINOSINUSITIS; ALLERGIC INFLAMMATION; CYTOKINE PRODUCTION; ASTHMATIC AIRWAYS; EXPRESSION;
D O I
10.1016/j.jaci.2015.10.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Prostaglandin (PG) D-2 is the dominant COX product of mast cells and is an effector of aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease (AERD). Objective: We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells to generate PGD(2) and facilitate tissue eosinophilia and nasal polyposis in patients with AERD. Methods: Urinary eicosanoid levels were measured in aspirin-tolerant control subjects and patients with AERD. Nasal polyp specimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR, Western blotting, and immunohistochemistry. Human cord blood-and peripheral blood-derived mast cells were stimulated with TSLP in vitro to assess PGD(2) generation. Results: Urinary levels of a stable PGD(2) metabolite (uPGD-M) were 2-fold higher in patients with AERD relative to those in control subjects and increased further during aspirin-induced reactions. Peak uPGD-Mlevels during aspirin reactions correlated with reductions in blood eosinophil counts and lung function and increases in nasal congestion. Mast cells sorted from nasal polyps expressed PGD(2) synthase (hematopoietic PGD(2) synthase) mRNA at higher levels than did eosinophils from the same tissue. Whole nasal polyp TSLP mRNA expression correlated strongly with mRNA encoding hematopoietic PGD(2) synthase (r = .75), the mast cell-specific marker carboxypeptidase A3 (r = .74), and uPGD-M (r=0.74). Levels of the cleaved active form of TSLP were increased in nasal polyps from patients with AERD relative to those in aspirin-tolerant control subjects. Recombinant TSLP induced PGD(2) generation by cultured human mast cells. Conclusions: Our study demonstrates that mast cell-derived PGD(2) is a major effector of type 2 immune responses driven by TSLP and suggests that dysregulation of this innate system contributes significantly to the pathophysiology of AERD.
引用
收藏
页码:1566 / +
页数:16
相关论文
共 50 条
  • [21] Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease
    Choi, Y.
    Lee, D. -H.
    Trinh, H. K. T.
    Ban, G. -Y.
    Park, H. -K.
    Shin, Y. S.
    Kim, S. -H.
    Park, H. -S.
    ALLERGY, 2019, 74 (01) : 78 - 88
  • [22] Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis
    White, Andrew A.
    Doherty, Taylor A.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2018, 32 (01) : 7 - 11
  • [23] Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease
    Hayashi, Hiroaki
    Fukutomi, Yuma
    Mitsui, Chihiro
    Kajiwara, Keiichi
    Watai, Kentaro
    Tomita, Yasuhiro
    Kamide, Yosuke
    Tsuburai, Takahiro
    Sekiya, Kiyoshi
    Ishii, Makoto
    Hasegawa, Yoshinori
    Taniguchi, Masami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (06) : 1667 - +
  • [24] Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease
    Bochenek, Grazyna
    Szafraniec, Krystyna
    Kuschill-Dziurda, Joanna
    Nizankowska-Mogilnicka, Ewa
    RESPIRATORY MEDICINE, 2015, 109 (05) : 588 - 595
  • [25] Chronic Rhinosinusitis Outcomes of Patients With Aspirin-Exacerbated Respiratory Disease Treated With Budesonide Irrigations: A Case Series
    Talat, Rehab
    Gengler, Isabelle
    Phillips, Katie M.
    Caradonna, David S.
    Gray, Stacey T.
    Sedaghat, Ahmad R.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2022, 131 (10): : 1130 - 1136
  • [26] The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data
    San Nicolo, Marion
    Hoegerle, Catalina
    Gellrich, Donata
    Eder, Katharina
    Pfrogner, Elisabeth
    Groeger, Moritz
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (02) : 445 - 452
  • [27] Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease
    Mitsui, Chihiro
    Kajiwara, Keiichi
    Hayashi, Hiroaki
    Ito, Jun
    Mita, Haruhisa
    Ono, Emiko
    Higashi, Noritaka
    Fukutomi, Yuma
    Sekiya, Kiyoshi
    Tsuburai, Takahiro
    Akiyama, Kazuo
    Yamamoto, Kazuhiko
    Taniguchi, Masami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : 400 - 411
  • [28] Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma
    Bochenek, Grazyna
    Stachura, Tomasz
    Szafraniec, Krystyna
    Plutecka, Hanna
    Sanak, Marek
    Nizankowska-Mogilnicka, Ewa
    Sladek, Krzysztof
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (02): : 528 - 535
  • [29] Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients
    Shah, Sharan J.
    Abuzeid, Waleed M.
    Ponduri, Anusha
    Pelletier, Teresa
    Ren, Zhen
    Keskin, Taha
    Roizen, Gigia
    Rosenteich, David
    Ferastraoaru, Denisa
    Jerschow, Elina
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2019, 9 (12) : 1401 - 1408
  • [30] Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease
    Mortazavi, Negar
    Esmaeilzadeh, Hossein
    Abbasinazari, Mohammad
    Babaie, Delara
    Alyasin, Soheila
    Nabavizadeh, Hesamodin
    Esmailzadeh, Elmira
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (04): : 1639 - 1647